FDA clears Cryocare's Percutaneous Access introducer:
This article was originally published in Clinica
Executive Summary
Endocare has received US FDA 510(k) clearance to market its Percutaneous Access Introducer, which is designed for use with the company's Cryocare Surgical System during urological cryosurgery. The new device establishes direct access into the prostate, enabling faster and easier placement of the Cryoprobe, which freezes and destroys tumours without affecting surrounding healthy tissue, said the Irvine, California company.